Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 10071  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
Read this article


    Article Cited by others


Imatinib induced pyoderma gangrenosum

Pinato D J, Sharma R

Year : 2013| Volume: 59| Issue : 3 | Page no: 244-245

   This article has been cited by
1 Tyrosine kinase inhibitors-associated pyoderma gangrenosum, a systematic review of published case reports
Niloofar Khoshnam-Rad, Azin Gheymati, Zahra Jahangard-Rafsanjani
Anti-Cancer Drugs. 2022; 33(1): e1
[Pubmed]  [Google Scholar] [DOI]
2 Imatinib-induced pyoderma gangrenosum in a patient with chronic myeloid leukemia
Andrea Giuseppe Faraci, Giovanni Genovese, Silvia Ferrucci, Angelo Valerio Marzano
Indian Journal of Dermatology, Venereology and Leprology. 2021; 87: 704
[Pubmed]  [Google Scholar] [DOI]
3 Papel de las citocinas en el pioderma gangrenoso
Víctor Alfonso Santos, William López, Carlos A. Cañas, Gabriel J. Tobón
Piel. 2019; 34(2): 94
[Pubmed]  [Google Scholar] [DOI]
4 Rituximab Causing Deep Ulcerative Suppurative Vaginitis/Pyoderma Gangrenosum
Priya Selva-Nayagam,Gayle Fischer,Ian Hamann,Jack Sobel,Craig James
Current Infectious Disease Reports. 2015; 17(5)
[Pubmed]  [Google Scholar] [DOI]
5 Imatinib
Reactions Weekly. 2013; 1475(1): 22
[Pubmed]  [Google Scholar] [DOI]
6 Sunitinib et pyoderma gangrenosum
J.-L. Schmutz,P. Trechot
Annales de Dermatologie et de Vénéréologie. 2013;
[Pubmed]  [Google Scholar] [DOI]


Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow